Overview of Notice of Funding Opportunity Announcement (NOFO): PS23-2302
Accelerating the Prevention and Control of HIV, Viral Hepatitis, STDs, and TB in the U.S.–Affiliated Pacific Islands also known as the PS23-2302 Notice of Funding Opportunity (NOFO) is a 5-year cooperative agreement supported by the Centers for Disease Control and Prevention (CDC) that builds on the previous PS13-1301 and PS18-1801 NOFOs.
PS23-2302 is an integrated NOFO that supports the National Center for HIV, Viral Hepatitis, STD and TB Prevention (NCHHSTP) strategy to increase program collaboration and service integration (PCSI) through enhanced engagement, knowledge sharing, integration across prevention and treatment services, and consolidated administrative processes. The NOFO will support recipients to:
- Implement PCSI to capitalize on opportunities to perform diagnostic testing, treat, and prevent infections in persons with similar risk factors
- Improve the collection, reporting, use, and sharing of surveillance data
- Develop public healthcare workforce through training and education
- Strengthen laboratory quality management systems and improve capacity to conduct reliable, accurate, and timely testing
- Enhance prevention, care, and treatment activities for specific diseases
- Informational Conference Call:
June 28, 2022, at 7:00 PM (EDT) - Application Due Date:
July 31, 2022, at 11:59 PM (EDT)
Slides from the Informational Call [PDF – 1.3 MB]
Review the slide deck presented during the Informational Conference Call held June 28, 2022
Strategies, Outcomes, and Activities
To achieve the long-term outcomes, applicants will be required to implement activities under five main strategies:
Strategy 1: Program Collaboration and Service Integration (PCSI)
Outcome
- Increased receipt of testing and treatment for multiple diseases as clinically indicated among patients
Activities
- Implement integrated screening and testing in high priority settings
- Integrate screening and testing of persons at risk for multiple diseases
Strategy 2: Surveillance, Data Management, and Reporting
Outcomes
- Increased complete and timely data reporting for USAPIs
- Improved prevention programs and service delivery among disproportionately affected populations
Activities
- Collect and manage surveillance and program data
- Evaluate program effectiveness
- Implement quality assurance processes
- Use and disseminate data to drive public health action
- Implement the current NCHHSTP Data Security and Confidentiality Guidelines
Strategy 3: Workforce Development
Outcome
- Increased public healthcare workforce skills to deliver prevention, screening, and care services for HIV, VH, STDs, and TB
Activities
- Designate a TB Education and Training Focal Point who will become a member (if not already) of the TB Education and Training Network (TB ETN)
- Build public healthcare workforce capacity
- Participate in CDC-sponsored conferences and meetings
- Develop and/or update policies and procedures to support program implementation across PCSI programs
Strategy 4: Laboratory Strengthening
Outcomes
- Improved availability of laboratory supplies within the expiration date
- Improved availability of high-quality testing services
- Decreased turnaround times for HIV, hepatitis B, STD, and TB testing
Activities
- Deliver reliable, accurate, and timely public health laboratory services and ensure strong laboratory quality management systems
- Evaluate laboratory data/practices and address needed improvements
Strategy 5: Disease-Specific Prevention and Care
Outcomes
- Increased awareness of HIV, hepatitis B, and STD or TB infection
- Increased timely linkage to care for persons diagnosed with HIV, VH, STDs, and TB
- Increased receipt of partner services and completion of contact investigations
- Improved care outcomes for patients with diagnosed infection
Activities
- Conduct or facilitate high impact prevention including: prevention, screening, testing, linkage to care, treatment, and case management
- Provide partner services and contact investigation
Funding
PS23-2302 is supported by the Division of HIV Prevention, Division of Viral Hepatitis, Division of STD Prevention, and the Division of TB Elimination, in NCHHSTP at CDC. In FY 2023, $3,900,000 million is anticipated to be awarded for Year 1 activities beginning January 2023, with up to six applicants expected to be funded. The total projected estimated funding for the entire 5-year project period is $19,500,000 million.
Eligibility
- Foreign Institutions Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
- Applicant must provide proof of ability to serve populations in one of the jurisdictions listed below:
- Commonwealth of the Northern Mariana Islands (CNMI)
- American Samoa
- Guam
- Federated States of Micronesia (FSM)
- Republic of the Marshall Islands (RMI)
- Republic of Palau
Evidence of ability may include documentation that applicant is a territorial government or a bona fide agent in American Samoa, the Commonwealth of the Northern Mariana Islands, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, or the Republic of Palau. Documentation must be provided in an attachment labeled (EvidenceofAbility.)
A bona fide agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with “Other Attachment Forms” when submitting via grants.gov.
If applicant is other than a Department/Ministry of Health in the specified jurisdiction, the applicant must submit a memorandum of agreement/memorandum of understanding with the Department/Ministry of Health in the jurisdiction for which it is applying. The memorandum of agreement/memorandum of understanding should include the authority to collect and submit surveillance data. Documentation must be provided in attachment labeled (MOUwith(insert name of Department/Ministry of Health)). Attach with “Other Attachment Forms” when submitting via grants.gov.
Next Steps
